Skip to content

Clinical trials

Phase 4 Myocardial Infarction trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 4 Country / region: Norway Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20112
20161
20182
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital2
Boehringer Ingelheim1
Helse Stavanger HF1
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz1
Maasstad Hospital1
Ole Frobert, MD, PhD1
Uppsala University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction8
ST Elevation Myocardial Infarction3
Cardiovascular Diseases2
Heart Failure2
Infarction2
Acute Coronary Syndrome1
Heart Diseases1
Hemorrhage1
Influenza, Human1
Ischemia1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.